BNO bionomics limited
Add to My Watchlist 0.00% ! 1.0¢

fda approval for linaclotide

  1. ooberdoober
    143 Posts.
    clock Created with Sketch.
    31/08/12
    15:18
    Post #: 10654070
    31 August 2012: Bionomics Limited (ASX:BNO, ADR: BMICY) BNC210 partner Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) achieved a major milestone overnight by gaining US FDA approval for linaclotide. The drug, to treat chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C), will be sold under the brand name LINZESSTM.
    BNO Price at posting: 32.8¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner
right-arrow Created with Sketch.
NEWS Strategic investment secured for QLD and NSW bauxite projects
right-arrow Created with Sketch.
NEWS Drilling to commence at FAU’s Gimlet high-grade gold project following approvals
right-arrow Created with Sketch.
3DA Amaero’s big move: Exclusive deal, big targets, and a lot on the line
right-arrow Created with Sketch.
NEWS New channel sampling confirms further copper at Graceland, Namibia
right-arrow Created with Sketch.
NEWS Strong soil results define new gold targets at Tole and Dadjan
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.